Tandem Diabetes Care, Inc.
$16.87
Market Cap
$1.20B
Shares Outstanding
69.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 14, 2013
Round Lot
100
Locale
US
Day Open
$17.13
Day High
$17.15
Day Low
$16.77
Volume
2.28M
VWAP
$16.90
Prev Close
$17.23
Transactions
--
Acc. Volume
--
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Tandem Diabetes Care, Inc. (TNDM) closed the 2026-09-18 session at $16.87, down 2.09% versus the previous close (-0.36). The stock opened at $17.13 and traded between $16.77 and $17.15 during that session. Session trading volume was 2.3M shares. The volume-weighted average price (VWAP) is $16.90.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Tandem Diabetes Care, Inc. has a market capitalization of $1.20 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. TNDM is listed on the XNAS exchange. The company employs approximately 2,500 people. Tandem Diabetes Care, Inc. is headquartered in San Diego, CA. The recorded listing date is 2013-11-14.
On this page you can find market TNDM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.